Healthcare, Pharma & Life Sciences

Linearis Labs Wins Two TFRI Grants in $40.9M AI Health Fund

Image
Linearis Labs Wins Two TFRI Grants in $40.9M AI Health Fund

Québec City – September 19, 2026 -- Linearis Labs has secured funding for two projects under the Terry Fox Research Institute's (TFRI) Digital Health Innovation Fund, part of a combined $40.9 million investment spread across 14 pan-Canadian project teams and 55 partners.

TFRI backs 14 projects with $40.9 million to advance AI-driven precision medicine

The funding, distributed through TFRI's Digital Health & Discovery Platform (DHDP), targets AI-driven health data sharing for precision medicine nationwide. TFRI President and Scientific Director Dr. Jim Woodgett said the initiative reflects research and enterprise coming together to drive innovation.

Medisights AI Agents Map CAR-T Referral Gaps in Multiple Myeloma

New York – September 19, 2026 -- Medisights, an AI-native platform for life sciences, has completed a study showing purpose-built AI agents can compress months of qualitative physician research into days while tracking the fast-shifting multiple myeloma treatment landscape.

AI moderators sustain 45-to-60-minute physician interviews to map CAR-T referral logic

Medisights' clinical-grade AI conducted adaptive, humanized conversations with specialists, with interviews routinely running 45 to 60 minutes -- longer engagement than traditional researchers typically secure with physicians. The extended dialogue captured prescribing rationale and geographic variation in CAR-T referral pathways for multiple myeloma, a disease marked by rapidly evolving treatment practices.

AZ Blue Health Choice Links 3,000 Backpacks to Child Wellness Visits

Image
AZ Blue Health Choice Links 3,000 Backpacks to Child Wellness Visits

PHOENIX – September 19, 2026 -- Blue Cross Blue Shield of Arizona Health Choice (AZ Blue Health Choice) is distributing approximately 3,000 backpacks filled with school supplies to Medicaid families across Arizona this year, tying the giveaway directly to a push for increased preventive pediatric care.

Backpack Distribution Ties School Supplies to Well-Child Visit Access

AZ Blue Health Choice partnered with Equality Health Foundation on the initiative, which supplies notebooks, folders, pencils, crayons, rulers and glue sticks to children and families statewide. The program is structured around partnerships with pediatric and primary care practices to connect families with annual wellness visits, aiming to identify health issues early and reduce financial strain on households ahead of the school year.

Myosin Therapeutics Named to NCI's 2026-2027 Investor Showcase

Image
Myosin Therapeutics Named to NCI's 2026-2027 Investor Showcase

Jupiter, Florida – September 19, 2026 -- Myosin Therapeutics, Inc. has been selected as one of just 30 companies for the National Cancer Institute's 2026–2027 Investor Initiatives Showcase, a distinction drawn from NCI's full portfolio of funded companies following a competitive review by more than 70 third-party investors and strategic partners.

NCI selects Myosin from a competitive field of oncology innovators

The 2026–2027 cohort spans biopharmaceuticals, medical devices, diagnostics and digital health, covering first-in-class therapeutics, cell and immune therapies, radioligand therapies, antibody-drug conjugates, RNA medicines, precision drug delivery, AI-enabled cancer technologies, liquid biopsy and multi-omics platforms. Myosin enters this group with a mechanics-based approach that targets molecular nanomotors underlying cancer cell growth, invasion and survival.

Troy Aikman Takes Ownership Stake in Qualia Life Sciences

Image
Troy Aikman Takes Ownership Stake in Qualia Life Sciences

Carlsbad, Calif. – September 19, 2026 -- Hall of Fame quarterback and broadcaster Troy Aikman has taken an ownership stake in Qualia Life Sciences, a supplement brand founded in 2015 that has built its reputation on human clinical studies conducted on every formula prior to release.

Aikman moves from potential endorser to equity owner in longevity brand

Aikman, a three-time Super Bowl champion and current broadcaster on the third most-watched television show in America, said he has historically turned down endorsement offers from nutritional brands due to skepticism about efficacy. He credited Qualia's supplements with personally sustaining his energy, fitness, and mental sharpness at age 59, stating the results convinced him to join the company's ownership team rather than simply lend his name.

Kibow Biotech's Website Wins Best Science Site at 2026 WebAwards

Image
Kibow Biotech's Website Wins Best Science Site at 2026 WebAwards

Exton, Pa. – September 19, 2026 -- Kibow Biotech's redesigned website, KibowBiotech.com, has been named Best Science Website in the 2026 WebAward Competition, run by the Web Marketing Association across seven judging criteria including design, innovation, content and ease of use.

Kibow expands Renadyl distribution into Canada as part of global rollout

The company's flagship product, Renadyl®, a clinically studied probiotic dietary supplement built on gut-kidney axis research, is now sold worldwide, with an upcoming expansion into Canada marking the latest step in Kibow's international access strategy.

Kibow prepares Renaphil launch to extend kidney probiotic science to pets

The company is developing RenaphilTM, a kidney probiotic formulated specifically for cats and dogs, applying nearly 30 years of gut-kidney research to companion-animal health.

I AM ALS Delivers 20,100+ Signatures to Save ACT for ALS Law

Washington – September 19, 2026 -- More than 20,100 Americans signed a petition in just four days demanding Congress reauthorize the Accelerating Access to Critical Therapies (ACT) for ALS law before its September 19, 2026 expiration date.

Petition drive targets key congressional committees ahead of deadline

The campaign, organized by advocacy group I AM ALS during its annual Week of Impact, directs the petition at Senate HELP Committee and House Energy and Commerce Committee leadership. Signatories include patients living with ALS, caregivers, researchers, and clinicians who rely on programs the law established.

First Health Advisory Launches Resilience360 for Hospital Continuity

Image
First Health Advisory Launches Resilience360 for Hospital Continuity

Washington – September 19, 2026 -- First Health Advisory has launched Resilience360, a consulting program designed to validate whether hospitals and health systems can keep clinical operations running during cyberattacks, technology outages, third-party failures, and natural disasters.

Program targets the gap between disaster recovery plans and actual clinical continuity

Healthcare organizations have invested heavily in disaster recovery, incident response, and emergency preparedness, but many have not validated how clinical and operational workflows will continue functioning while systems are being restored, according to First Health Advisory. Resilience360 is built to close that gap by testing the people, processes, and workflows required to sustain patient care throughout a disruption, rather than adding another compliance framework.

ProBio, Kun Tuo Partner to Fast-Track Cell and Gene Therapy Trials in China

Image
ProBio, Kun Tuo Partner to Fast-Track Cell and Gene Therapy Trials in China

Hopewell, N.J. – September 19, 2026 -- ProBio, a global contract development and manufacturing organization (CDMO), has struck a strategic collaboration with Kun Tuo, an IQVIA-owned clinical research organization (CRO) in China, to integrate manufacturing and clinical trial execution for advanced therapies.

Partnership links CDMO manufacturing with CRO trial operations in China

The alliance combines ProBio's biologics and cell and gene therapy (CGT) development and manufacturing platform with Kun Tuo's clinical trial management network, targeting faster Investigator-Initiated Trials (IITs) for global biopharma sponsors entering the Chinese market. The integrated offering spans Chemistry, Manufacturing and Controls (CMC), non-clinical studies, and clinical operations under a single coordinated pathway.

Bambu Lab Launches 24-Brief Global 3D-Printing Accessibility Contest

Image
Bambu Lab Launches 24-Brief Global 3D-Printing Accessibility Contest

Austin, Texas – September 19, 2026 -- Bambu Lab has launched a global design challenge on MakerWorld with seven accessibility organizations, issuing 24 design briefs between September and December 2026 that ask makers to produce 3D-printable aids for people with disabilities.

MakerWorld mobilizes its designer community around specific disability needs

The challenge marks the first time MakerWorld, described as the world's largest community of 3D-printing makers, has organized its designers around concrete briefs tied to named individuals and documented daily obstacles. Partner organizations include Ayúdame3D, the Emerging Tech Lab at Rancho Los Amigos National Rehabilitation Center, e-NABLE France, MakeGood, Makers Making Change (Neil Squire Society), PrintLab, and Rightfooted Foundation International.